HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress

Molecular Cell

Volumn 52, Issue 3, 2013, Pages 406-420

  Sen, Nirmalya ^a   Kumari, Rajni ^a   Singh, ManikaIndrajit ^a   Das, Sanjeev ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 5; PROTEIN P53;

ACETYLATION; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DOWN REGULATION; GENOTOXIC STRESS; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEOMICS; STRESS; TRANSACTIVATION;

MUS;

EID: 84887161736     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.09.003     Document Type: Article

References (28)

1. Beckerman R., Prives C. Transcriptional regulation by p53. Cold Spring Harb. Perspect. Biol. 2010, 2:a000935.
2. Bradbury C.A., Khanim F.L., Hayden R., Bunce C.M., White D.A., Drayson M.T., Craddock C., Turner B.M. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 2005, 19:1751-1759.
3. Das S., Somasundaram K. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer invitro and invivo. Cancer Biol. Ther. 2006, 5:210-217.
4. Downes M., Ordentlich P., Kao H.Y., Alvarez J.G., Evans R.M. Identification of a nuclear domain with deacetylase activity. Proc. Natl. Acad. Sci. USA 2000, 97:10330-10335.
5. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., Bartlett R.K., Lowe J.S., O'Donnell S.E., Aykin-Burns N., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
6. Greco T.M., Yu F., Guise A.J., Cristea I.M. Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. Mol. Cell. Proteomics 2011, 10:004317.
7. Grozinger C.M., Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 2000, 97:7835-7840.
8. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90:595-606.
9. Han J.A., Kim J.I., Ongusaha P.P., Hwang D.H., Ballou L.R., Mahale A., Aaronson S.A., Lee S.W. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J. 2002, 21:5635-5644.
10. Ito A., Kawaguchi Y., Lai C.H., Kovacs J.J., Higashimoto Y., Appella E., Yao T.P. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 2002, 21:6236-6245.
11. Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y., Birnbaum M.J., Thompson C.B. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 2005, 18:283-293.
12. Knights C.D., Catania J., Di Giovanni S., Muratoglu S., Perez R., Swartzbeck A., Quong A.A., Zhang X., Beerman T., Pestell R.G., Avantaggiati M.L. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J.Cell Biol. 2006, 173:533-544.
13. Li T., Kon N., Jiang L., Tan M., Ludwig T., Zhao Y., Baer R., Gu W. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012, 149:1269-1283.
14. Linseman D.A., Bartley C.M., Le S.S., Laessig T.A., Bouchard R.J., Meintzer M.K., Li M., Heidenreich K.A. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J.Biol. Chem. 2003, 278:41472-41481.
15. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001, 107:137-148.
16. McKinsey T.A., Zhang C.L., Lu J., Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408:106-111.
17. McKinsey T.A., Zhang C.L., Olson E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 2000, 97:14400-14405.
18. Mellert H.S., Stanek T.J., Sykes S.M., Rauscher F.J., Schultz D.C., McMahon S.B. Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis. J.Biol. Chem. 2011, 286:4264-4270.
19. Milde T., Oehme I., Korshunov A., Kopp-Schneider A., Remke M., Northcott P., Deubzer H.E., Lodrini M., Taylor M.D., von Deimling A., et al. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin. Cancer Res. 2010, 16:3240-3252.
20. Narita M., Nũnez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
21. Ozdaǧ H., Teschendorff A.E., Ahmed A.A., Hyland S.J., Blenkiron C., Bobrow L., Veerakumarasivam A., Burtt G., Subkhankulova T., Arends M.J., et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 2006, 7:90.
22. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
23. Sykes S.M., Mellert H.S., Holbert M.A., Li K., Marmorstein R., Lane W.S., McMahon S.B. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 2006, 24:841-851.
24. Tang Y., Luo J., Zhang W., Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 2006, 24:827-839.
25. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
26. Wang C., Ivanov A., Chen L., Fredericks W.J., Seto E., Rauscher F.J., Chen J. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 2005, 24:3279-3290.
27. Yang X.J., Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007, 26:5310-5318.
28. Zhu W., Woo A.Y., Yang D., Cheng H., Crow M.T., Xiao R.P. Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J.Biol. Chem. 2007, 282:10833-10839.